StocksFin Logo
Zoetis Inc. country of incorporation
|
|
Mr. Juan Alaix
|
12,100 employees
NYSE | Healthcare | Drug Manufacturers—Specialty & Generic
Boston Scientific Corporation country of incorporation
|
|
Mr. Michael Mahoney
|
41,000 employees
NYSE | Healthcare | Medical Devices
Q322 reported Nov 3, 2022 Reporting Period
$2B 0.6% vs. Q321 Revenues Q322
69.68% -1.2% vs. Q321 Gross Profit Margin
26.42% -4.7% vs. Q321 Net Profit Margin
372M -43% vs. Q321 Free Cash Flow Q322
$1.13 -2.6% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.22%
Q322
0.03%
Q322 reported Nov 3, 2022 Reporting Period
$3.17B 8.1% vs. Q321 Revenues Q322
69.12% 0.4% vs. Q321 Gross Profit Margin
5.49% -61.6% vs. Q321 Net Profit Margin
320M -31.2% vs. Q321 Free Cash Flow Q322
$0.12 -57.1% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.22%
Q322
0.03%
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
1.28
0.62
Current Ratio
2.27
1.45
Cash Ratio
0.87
0.1
Price to Book
14.88
3.14
Price to Sales
34.65
17.49
Price to Earnings
32.78
79.66